The Latest Research News

Study: Plasma Therapy Effective At Early Stage

The Times of India, December 26, 2021 Days after the World Health Organization (WHO) recommended against the use of plasma therapy for Covid-19, a multi-centre clinical trial led by Johns Hopkins Medicine and the Johns Hopkins Bloomberg School of Public Health has reiterated the treatment is beneficial indeed.

Johns Hopkins Receives Award for Antimicrobial Resistance Surveillance and Infection Control Partnership in India

Johns Hopkins India Institute, December 13, 2021 Drs. Matthew Robinson and Trish Simner of Johns Hopkins School of Medicine are collaborating with five Indian medical institutions with which JHU has longstanding research ties

News Release: CDC Launches Two Global Networks, Awards $22 Million to Combat Antimicrobial Resistance and Infectious Diseases

US Centers for Disease Control and Prevention, December 07, 2021 These two new networks, paired with additional short-term research projects, will span more than 50 countries worldwide and build programs that focus on preventing infections in health care through proven infection control; build laboratory capacity to detect antimicrobial-resistant organisms in healthcare, the community, and environment; and develop new and innovative ways to more rapidly detect and respond to threats like AR and COVID-19.